What Price Better Health? : Hazards of the Research Imperative /
The idea that we have an unlimited moral imperative to pursue medical research is deeply rooted in American society and medicine. In this provocative work, Daniel Callahan exposes the ways in which such a seemingly high and humane ideal can be corrupted and distorted into a harmful practice. Medical...
Clasificación: | Libro Electrónico |
---|---|
Autor principal: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Berkeley, CA :
University of California Press,
[2003]
|
Colección: | California/Milbank Books on Health and the Public ;
9 |
Temas: | |
Acceso en línea: | Texto completo Texto completo |
MARC
LEADER | 00000nam a22000005i 4500 | ||
---|---|---|---|
001 | DEGRUYTERUP_9780520939233 | ||
003 | DE-B1597 | ||
005 | 20220524034747.0 | ||
006 | m|||||o||d|||||||| | ||
007 | cr || |||||||| | ||
008 | 220524t20032003cau fo d z eng d | ||
010 | |a 2021697122 | ||
020 | |a 9780520939233 | ||
024 | 7 | |a 10.1525/9780520939233 |2 doi | |
035 | |a (DE-B1597)521094 | ||
035 | |a (OCoLC)55538435 | ||
040 | |a DE-B1597 |b eng |c DE-B1597 |e rda | ||
041 | 0 | |a eng | |
044 | |a cau |c US-CA | ||
050 | 0 | 0 | |a R853.S64 |
050 | 4 | |a R853.S64 |b C35 2003 | |
072 | 7 | |a MED036000 |2 bisacsh | |
082 | 0 | 4 | |a 610.72073 |2 21/eng |
100 | 1 | |a Callahan, Daniel, |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
245 | 1 | 0 | |a What Price Better Health? : |b Hazards of the Research Imperative / |c Daniel Callahan. |
264 | 1 | |a Berkeley, CA : |b University of California Press, |c [2003] | |
264 | 4 | |c ©2003 | |
300 | |a 1 online resource (341 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a text file |b PDF |2 rda | ||
490 | 0 | |a California/Milbank Books on Health and the Public ; |v 9 | |
506 | 0 | |a restricted access |u http://purl.org/coar/access_right/c_16ec |f online access with authorization |2 star | |
520 | |a The idea that we have an unlimited moral imperative to pursue medical research is deeply rooted in American society and medicine. In this provocative work, Daniel Callahan exposes the ways in which such a seemingly high and humane ideal can be corrupted and distorted into a harmful practice. Medical research, with its power to attract money and political support, and its promise of cures for a wide range of medical burdens, has good and bad sides-which are often indistinguishable. In What Price Better Health?, Callahan teases out the distinctions and differences, revealing the difficulties that result when the research imperative is suffused with excessive zeal, adulterated by the profit motive, or used to justify cutting moral corners. Exploring the National Institutes of Health's annual budget, the inflated estimates of health care cost savings that result from research, the high prices charged by drug companies, the use and misuse of human subjects for medical testing, and the controversies surrounding human cloning and stem cell research, Callahan clarifies the fine line between doing good and doing harm in the name of medical progress. His work shows that medical research must be understood in light of other social and economic needs and how even the research imperative, dedicated to the highest human good, has its limits. | ||
538 | |a Mode of access: Internet via World Wide Web. | ||
546 | |a In English. | ||
588 | 0 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 24. Mai 2022) | |
650 | 0 | |a Medicine |x Research |x Social aspects |x United States. | |
650 | 0 | |a Medicine |x Research |x Social aspects |z United States. | |
650 | 0 | |a Research. | |
650 | 7 | |a MEDICAL / Health Policy. |2 bisacsh | |
653 | |a american medicine. | ||
653 | |a american society. | ||
653 | |a annual budgets. | ||
653 | |a bioethics. | ||
653 | |a boundaries of science. | ||
653 | |a capitalist society. | ||
653 | |a controversial. | ||
653 | |a drug companies. | ||
653 | |a economic needs. | ||
653 | |a health care costs. | ||
653 | |a health care system. | ||
653 | |a health researchers. | ||
653 | |a human cloning. | ||
653 | |a human subjects. | ||
653 | |a limits of research. | ||
653 | |a medical burdens. | ||
653 | |a medical progress. | ||
653 | |a medical research. | ||
653 | |a medical testing. | ||
653 | |a moral issues. | ||
653 | |a morality. | ||
653 | |a political history. | ||
653 | |a profit motives. | ||
653 | |a research imperative. | ||
653 | |a social needs. | ||
653 | |a sociology. | ||
653 | |a stem cell research. | ||
773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t University of California Press Backlist Package 2000-2013 |z 9783110690422 |
856 | 4 | 0 | |u https://doi.uam.elogim.com/10.1525/9780520939233 |z Texto completo |
856 | 4 | 0 | |u https://degruyter.uam.elogim.com/isbn/9780520939233 |z Texto completo |
912 | |a 978-3-11-069042-2 University of California Press Backlist Package 2000-2013 |c 2000 |d 2013 | ||
912 | |a EBA_FAO | ||
912 | |a EBA_UCA_YUP | ||
912 | |a GBV-deGruyter-alles |